Researchers at the University of California San Diego School of Medicine found that patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego Health were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy.
The phase III CheckMate-816 trial met a primary endpoint of pathologic complete response in resectable non-small cell lung cancer.
One of the more complex tasks that I performed in my medical oncology practice was enrolling patients on a clinical trial.
Kelvin Lee was named director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Jan Kitajewski was named director of the University of Illinois Cancer Center, effective Oct. 16, 2020.
Ira Pastan, distinguished investigator at NCI, has received the Paul A. Volcker Career Achievement Medal from the Partnership for Public Service for his discovery of moxetumomab pasudotox-tdfk (Lumoxiti), which is indicated for the treatment of relapsed or refractory hairy cell leukemia.
Thomas J. Fuchs was named co-director of the Hasso Plattner Institute for Digital Health at Mount Sinai, dean of artificial intelligence and human health, and professor of computational pathology and computer science in the Department of Pathology at the Icahn School of Medicine at Mount Sinai.
Kevin Kalinsky was named director of the Glenn Family Breast Center at Winship Cancer Institute of Emory University. Kalinsky was also named associate professor in Emory University School of Medicine's Department of Hematology and Medical Oncology.
David Gius was named associate cancer center director for translational research at the Mays Cancer Center, home to UT Health San Antonio MD Anderson.
Sarasota Memorial Healthcare Foundation has received $25 million from the Brian and Sheila Jellison Family Foundation.
